Ezetimibe 10 mg is the standard oral dose of this cholesterol‑lowering medication. Below is a quick reference to help you understand how it’s used, what to watch for, and when to seek further help.
| Topic | Key Points |
|-------|------------|
| Indication | • Primary or mixed hyperlipidemia (high LDL‑C, total cholesterol, or mixed dyslipidemia).
• Often added to statin therapy when LDL‑C goals aren’t met.
• Can be used in statin‑intolerant patients as monotherapy or with a low‑dose statin. |
| Typical Adult Dose | 10 mg once daily (usually with or without food).
• No higher approved dose in adults; 10 mg is the sole formulation. |
| Pharmacology | • Inhibits the NPC1L1 transporter in the small intestine, reducing dietary & biliary cholesterol absorption by ~50%.
• Has a half‑life of ~24 h; steady‑state achieved within ~1 week. |
| How It Works With Statins | • Statins block hepatic cholesterol synthesis; ezetimibe blocks intestinal absorption.
• The combination can lower LDL‑C by ~30–35 % (statin alone) + ~20 % (ezetimibe alone) → ~50–55 % total. |
| Common Adverse Effects | • Mild diarrhea, nausea, abdominal pain.
• Rare: headaches, dizziness, arthralgia.
• Very rare: hypersensitivity reactions, rash, eosinophilia. |
| Contraindications | • Known hypersensitivity to ezetimibe or any excipients.
• Severe hepatic impairment (ALT/AST >3× ULN).
• Concomitant use of potent CYP3A4 inhibitors (e.g., ketoconazole) is not contraindicated for ezetimibe itself, but monitor for statin‑related interactions if co‑prescribed. |
| Drug Interactions | • Statins: ↑ risk of myopathy if combined with statins metabolized by CYP3A4 (e.g., simvastatin, lovastatin).
• Antacids: can reduce absorption—take at least 1 h apart.
• Proton‑pump inhibitors: minimal impact, but check if you’re on high‑dose PPI.
• Other lipid‑lowering drugs: generally safe, but monitor lipid panel. |
| Special Populations | • Pregnancy: Category C – animal data show fetal toxicity; use only if clearly needed and no alternatives.
• Breastfeeding: limited data – consult a clinician.
• Renal impairment: no dose adjustment required.
• Pediatrics: FDA‑approved for ages 10+ when used with a statin; monotherapy not approved. |
| Monitoring | • Routine labs (CBC, LFTs) not required unless you’re on high‑dose statin therapy.
• Check lipid profile 4–12 weeks after starting or changing dose.
• Monitor for muscle symptoms if on concomitant statins. |
| Administration Tips | • Take once daily; can be with or without food.
• Do not crush or chew tablets; swallow whole.
• Store at room temperature, away from moisture. |
| What to Do If Missed a Dose | • Take as soon as you remember.
• Skip if it’s almost time for next dose.
• Do not double‑dose. |
---
Quick FAQ
| Question | Short Answer |
|----------|--------------|
| Can I take ezetimibe without a statin? | Yes, especially if you’re statin‑intolerant, but the LDL‑C lowering is modest (~20 %). |
| Will it help with triglycerides? | Minimal effect on triglycerides; primarily lowers LDL‑C. |
| Do I need to stop it if I start a new medication? | Talk to your prescriber—especially if the new drug is a statin or strong CYP3A4 inhibitor. |
| What if I feel muscle pain? | Report immediately; it could signal myopathy, especially if on a statin. |
| Is it safe during pregnancy? | Category C; use only if benefits outweigh risks. |
---
Bottom Line
- Standard dose: 10 mg orally once daily.
- Benefits: Reduces LDL‑C by ~20 % (monotherapy) or ~50 % when added to a statin.
- Side‑effects: Usually mild; serious reactions are rare.
- Key caution: Watch for drug interactions with statins and avoid use in severe liver disease.
If you have specific questions about your personal situation—e.g., drug interactions with your current regimen, dosing in liver disease, or pregnancy concerns—please bring them to your healthcare provider. They can tailor advice to your unique health profile.